MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.chest.2026.06.060

Медицинская библиотека · Chest · 2026

Using Historical Blood Eosinophil Counts to Guide Treatment Decisions in Patients With COPD.

Bafadhel Mona, Martinez Fernando J, Criner Gerard J, Tashkin Donald P, Wechsler Michael E, Han MeiLan K, Singh Dave

СтатьяОбзорПеревод в очереди

Аннотация

Up to 40% of patients with COPD have evidence of elevated eosinophil counts ≥ 300 cells/mL at some point during their disease. Blood eosinophil counts (BECs) are a biomarker that can identify patients with COPD and type 2 inflammation who are candidates for add-on inhaled corticosteroids (ICS) or biologic therapy. Evidence from real-world and clinical trial data shows variation in BECs over time in patients with COPD and type 2 inflammation. This How I Do It article discusses factors that can influence eosinophil counts, reviews how the use of historical eosinophil counts can inform treatment decisions, and provides practical considerations for identifying underlying type 2 inflammation in patients with COPD in the clinic. Currently, there is no consensus on what constitutes "low" or "high" BEC in COPD or the frequency or number of eosinophil measurements needed to effectively guide disease management. Based on our experience from the clinic and available literature, we propose 4 broad phenotypic groups of patients with COPD: those with BECs predominantly ≥ 300 cells/μL, intermittently ≥ 300 cells/μL, within an intermediate range of 100 to 300 cells/μL, and those with BECs predominantly < 100 cells/μL. Identifying these patterns can help with more precise stratification for pharmacologic interventions, such as adding inhaled corticosteroids or biologic therapies. Although single BEC measurements are easy to obtain and often sufficient to identify patients with COPD and high levels of type 2 inflammation, when interpreted alongside clinical characteristics, repeated BECs may be able to support a more personalized approach to COPD care.

Для цитирования: Bafadhel Mona, Martinez Fernando J, Criner Gerard J, Tashkin Donald P, Wechsler Michael E, Han MeiLan K, Singh Dave. Using Historical Blood Eosinophil Counts to Guide Treatment Decisions in Patients With COPD.. Chest. 2026. DOI: 10.1016/j.chest.2026.06.060.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.